1-183635564-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005717.4(ARPC5):c.96C>A(p.Asp32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005717.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPC5 | ENST00000359856.11 | c.96C>A | p.Asp32Glu | missense_variant | 1/4 | 1 | NM_005717.4 | ENSP00000352918.6 | ||
ARPC5 | ENST00000294742.6 | c.96C>A | p.Asp32Glu | missense_variant | 1/4 | 1 | ENSP00000294742.6 | |||
ARPC5 | ENST00000367534.5 | c.96C>A | p.Asp32Glu | missense_variant | 1/4 | 3 | ENSP00000356504.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249262Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135126
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1460916Hom.: 0 Cov.: 34 AF XY: 0.00000688 AC XY: 5AN XY: 726750
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74384
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.96C>A (p.D32E) alteration is located in exon 1 (coding exon 1) of the ARPC5 gene. This alteration results from a C to A substitution at nucleotide position 96, causing the aspartic acid (D) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at